| Ticker Details |
|
CeriBell, Inc. Common Stock
|
| IPO Date: |
October 11, 2024 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$750.07M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.50 | 2.65%
|
| Avg Daily Range (30 D): |
$0.41 | 1.92%
|
| Avg Daily Range (90 D): |
$0.44 | 2.54%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.26M |
| Avg Daily Volume (30 D): |
.26M |
| Avg Daily Volume (90 D): |
.34M |
| Trade Size |
| Avg Trade Size (Sh.): |
58 |
| Avg Trade Size (Sh.) (30 D): |
54 |
| Avg Trade Size (Sh.) (90 D): |
57 |
| Institutional Trades |
| Total Institutional Trades: |
213 |
| Avg Institutional Trade: |
$1.52M |
| Avg Institutional Trade (30 D): |
$.89M |
| Avg Institutional Trade (90 D): |
$1.14M |
| Avg Institutional Trade Volume: |
.07M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.59M |
| Avg Closing Trade (30 D): |
$.74M |
| Avg Closing Trade (90 D): |
$1.07M |
| Avg Closing Volume: |
77.73K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.37
|
$-.38
|
$-.36
|
|
Diluted EPS
|
$-.37
|
$-.38
|
$-.36
|
|
Revenue
|
$22.59M
|
$21.2M
|
$20.49M
|
|
Gross Profit
|
$19.94M
|
$18.68M
|
$18.01M
|
|
Net Income / Loss
|
$-13.47M
|
$-13.64M
|
$-12.78M
|
|
Operating Income / Loss
|
$-14.65M
|
$-14.95M
|
$-14.21M
|
|
Cost of Revenue
|
$2.65M
|
$2.52M
|
$2.48M
|
|
Net Cash Flow
|
$-16.4M
|
$-113.22M
|
$-41.01M
|
|
PE Ratio
|
|
|
|
|
|
|
